Zhang L - Search Results

1

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial.

Herbst RS, Sun Y, Eberhardt WE, Germonpré P, Saijo N, Zhou C, Wang J, Li L, Kabbinavar F, Ichinose Y, Qin S, Zhang L, Biesma B, Heymach JV, Langmuir P, Kennedy SJ, Tada H, Johnson BE. Herbst RS, et al. Among authors: zhang l. Lancet Oncol. 2010 Jul;11(7):619-26. doi: 10.1016/S1470-2045(10)70132-7. Lancet Oncol. 2010. PMID: 20570559 Free PMC article. Clinical Trial.

2

Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial.

Shi Y, Zhang L, Liu X, Zhou C, Zhang L, Zhang S, Wang D, Li Q, Qin S, Hu C, Zhang Y, Chen J, Cheng Y, Feng J, Zhang H, Song Y, Wu YL, Xu N, Zhou J, Luo R, Bai C, Jin Y, Liu W, Wei Z, Tan F, Wang Y, Ding L, Dai H, Jiao S, Wang J, Liang L, Zhang W, Sun Y. Shi Y, et al. Among authors: zhang l, zhang s, zhang w, zhang h, zhang y. Lancet Oncol. 2013 Sep;14(10):953-61. doi: 10.1016/S1470-2045(13)70355-3. Epub 2013 Aug 13. Lancet Oncol. 2013. PMID: 23948351 Clinical Trial.

3

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study.

Zhou C, Wu YL, Chen G, Feng J, Liu XQ, Wang C, Zhang S, Wang J, Zhou S, Ren S, Lu S, Zhang L, Hu C, Hu C, Luo Y, Chen L, Ye M, Huang J, Zhi X, Zhang Y, Xiu Q, Ma J, Zhang L, You C. Zhou C, et al. Among authors: zhang l, zhang s, zhang y. Lancet Oncol. 2011 Aug;12(8):735-42. doi: 10.1016/S1470-2045(11)70184-X. Epub 2011 Jul 23. Lancet Oncol. 2011. PMID: 21783417 Clinical Trial.

4

[Efficacy and safety of gefitinib monotherapy for Chinese elderly patients with advanced non-small cell lung cancer].

Zhang L, Wang SL, Zhang XT, Li LY, Wang MZ. Zhang L, et al. Among authors: zhang xt. Zhonghua Nei Ke Za Zhi. 2007 May;46(5):392-5. Zhonghua Nei Ke Za Zhi. 2007. PMID: 17637309 Chinese.

5

[Gefitinib in the treatment of advanced non-small cell lung cancer with brain metastasis].

Wu C, Li LY, Wang MZ, Zhang L, Zhang XT, Zhong W, Wang SL, Wang HZ. Wu C, et al. Among authors: zhang l, zhang xt. Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):943-5. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18478938 Clinical Trial. Chinese.

6

[Efficacy and safety of gefitinib in maintenance therapy for patients with advanced non-small cell lung cancer].

Wang MZ, Zhong W, Zhang L, Li LY, Wang SL, Li JR, Zhang XT. Wang MZ, et al. Among authors: zhang l, zhang xt. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):221-4. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756941 Clinical Trial. Chinese.

7

[Evaluation of efficacy and safety of ZD1839 as monotherapy in Chinese patients with advanced non-small cell lung cancer].

Wang MZ, Li LY, Wang SL, Zhang XT, Zhong W, Zhang L, Li JR. Wang MZ, et al. Among authors: zhang l, zhang xt. Zhonghua Nei Ke Za Zhi. 2008 Apr;47(4):291-5. Zhonghua Nei Ke Za Zhi. 2008. PMID: 18843952 Chinese.

8

[Efficacy and safety of erlotinib as monotherapy for advanced non-small cell lung cancer].

Wang MZ, Zhang XT, Zhang XY, Zhang L, Zhong W, Xu LY, Li LY. Wang MZ, et al. Among authors: zhang l, zhang xt, zhang xy. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010 Apr;32(2):151-6. doi: 10.3881/j.issn.1000-503X.2010.02.005. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010. PMID: 20450543 Clinical Trial. Chinese.

9

[Analysis of the efficacy and safety of gefitinib in the treatment of recurrent advanced non-small cell lung cancer in an expanded access program (EAP)].

Huang H, Zhang Y, Zhao HY, Wang ZQ, Xu F, Xu GC, Zhang L, Guan ZZ. Huang H, et al. Among authors: zhang l, zhang y. Zhonghua Zhong Liu Za Zhi. 2009 Feb;31(2):148-51. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19538895 Chinese.

10

Validation of a clinical prognostic model in Chinese patients with metastatic and advanced pretreated non-small cell lung cancer treated with gefitinib.

Wang F, Zhang Y, Zhao H, Chen L, Shi YX, Zhang L. Wang F, et al. Among authors: zhang l, zhang y. Med Oncol. 2011 Mar;28(1):331-5. doi: 10.1007/s12032-010-9451-1. Epub 2010 Mar 4. Med Oncol. 2011. PMID: 20204544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123,565 results

Search Page